John D. Pak

Array ( [id] => 7800674 [patent_doc_number] => 08128944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-06 [patent_title] => 'RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles' [patent_app_type] => utility [patent_app_number] => 12/670697 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 49 [patent_no_of_words] => 32457 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/128/08128944.pdf [firstpage_image] =>[orig_patent_app_number] => 12670697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463735 [patent_doc_number] => RE042373 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2011-05-17 [patent_title] => 'Adenovirus vectors containing cell status-specific response elements and methods of use thereof' [patent_app_type] => reissue [patent_app_number] => 12/221052 [patent_app_country] => US [patent_app_date] => 2008-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16147 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/042/RE042373.pdf [firstpage_image] =>[orig_patent_app_number] => 12221052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8994813 [patent_doc_number] => 08518698 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-08-27 [patent_title] => 'Method of promoting apoptosis of glioblastoma tumor cells' [patent_app_type] => utility [patent_app_number] => 12/168485 [patent_app_country] => US [patent_app_date] => 2008-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1821 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12168485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7519054 [patent_doc_number] => 07973156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'Hypoxia-regulated genes' [patent_app_type] => utility [patent_app_number] => 12/157821 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12920 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/973/07973156.pdf [firstpage_image] =>[orig_patent_app_number] => 12157821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273707 [patent_doc_number] => 20100299770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'TARGETED CELL DEATH' [patent_app_type] => utility [patent_app_number] => 12/664387 [patent_app_country] => US [patent_app_date] => 2008-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25647 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20100299770.pdf [firstpage_image] =>[orig_patent_app_number] => 12664387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568911 [patent_doc_number] => 20100273213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'METHOD FOR EXPRESSION OF SPECIFIC GENE' [patent_app_type] => utility [patent_app_number] => 12/664133 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13517 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273213.pdf [firstpage_image] =>[orig_patent_app_number] => 12664133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682284 [patent_doc_number] => 20100242127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'METHODS TO IDENTIFY MODULATORS OF B-RAF PROTEIN KINASE AND THEIR USE FOR THE TREATMENT OF ANXIETY AND DEPRESSION' [patent_app_type] => utility [patent_app_number] => 12/602753 [patent_app_country] => US [patent_app_date] => 2008-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16759 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20100242127.pdf [firstpage_image] =>[orig_patent_app_number] => 12602753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11749301 [patent_doc_number] => 09707299 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Targeted carriers for intracellular drug delivery' [patent_app_type] => utility [patent_app_number] => 12/600947 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22681 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12600947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4618758 [patent_doc_number] => 07998472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'CD34 stem cell-related methods and compositions' [patent_app_type] => utility [patent_app_number] => 12/154059 [patent_app_country] => US [patent_app_date] => 2008-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18204 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998472.pdf [firstpage_image] =>[orig_patent_app_number] => 12154059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4469945 [patent_doc_number] => 07943591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Gene expression and pain' [patent_app_type] => utility [patent_app_number] => 12/119435 [patent_app_country] => US [patent_app_date] => 2008-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32710 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943591.pdf [firstpage_image] =>[orig_patent_app_number] => 12119435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5292367 [patent_doc_number] => 20090025097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'SHRNA AND SIRNA AND MIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE' [patent_app_type] => utility [patent_app_number] => 12/118025 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 12106 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20090025097.pdf [firstpage_image] =>[orig_patent_app_number] => 12118025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272152 [patent_doc_number] => 20090075928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'G-QUARTET OLIGONUCLEOTIDES THAT TARGET HYPOXIA-INDUCIBLE FACTOR 1-a (HIF1a )' [patent_app_type] => utility [patent_app_number] => 12/117877 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27546 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075928.pdf [firstpage_image] =>[orig_patent_app_number] => 12117877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11429283 [patent_doc_number] => 09567591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Generation of human embryonic stem-like cells using intronic RNA' [patent_app_type] => utility [patent_app_number] => 12/149725 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21074 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12149725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4513641 [patent_doc_number] => 07910363 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-03-22 [patent_title] => 'Lipophilic polyamines providing enhanced intracellular delivery of agents by a polyamine transport system' [patent_app_type] => utility [patent_app_number] => 12/113970 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 15493 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910363.pdf [firstpage_image] =>[orig_patent_app_number] => 12113970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137091 [patent_doc_number] => 20110009474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'SIRTUIN BASED METHODS AND COMPOSITIONS FOR TREATING BETA-CATENIN-RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/595353 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 20066 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009474.pdf [firstpage_image] =>[orig_patent_app_number] => 12595353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6561142 [patent_doc_number] => 20100272697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'PANCREATIC ISLET CELLS COMPOSITION AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/595411 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10284 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272697.pdf [firstpage_image] =>[orig_patent_app_number] => 12595411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4719405 [patent_doc_number] => 20080241928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR ACID PHOSPHATASE-1 GENE INHIBITION' [patent_app_type] => utility [patent_app_number] => 12/056624 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11030 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241928.pdf [firstpage_image] =>[orig_patent_app_number] => 12056624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267776 [patent_doc_number] => 20100298413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'USE OF OLIGOTIDE FOR THE TREATMENT OF RENAL DISEASES' [patent_app_type] => utility [patent_app_number] => 12/596005 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2316 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298413.pdf [firstpage_image] =>[orig_patent_app_number] => 12596005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685987 [patent_doc_number] => 20100120154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'METHOD FOR HOMOLOGOUS RECOMBINATION' [patent_app_type] => utility [patent_app_number] => 12/532205 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10320 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120154.pdf [firstpage_image] =>[orig_patent_app_number] => 12532205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6421346 [patent_doc_number] => 20100151004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'MODULATION OF DRUG SENSITIVITY' [patent_app_type] => utility [patent_app_number] => 12/529916 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11853 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151004.pdf [firstpage_image] =>[orig_patent_app_number] => 12529916 [rel_patent_id] =>[rel_patent_doc_number] =>)